Cargando…
Targeting Cellular Metabolism Chemosensitizes the Doxorubicin-Resistant Human Breast Adenocarcinoma Cells
Metabolic energy preferentially produced by glycolysis was an advantageous metabolic phenotype of cancer cells. It is also an essential contributor to the progression of multidrug resistance in cancer cells. By developing human breast cancer MCF-7 cells resistant to doxorubicin (DOX) (MCF-7/MDR cell...
Autores principales: | Ma, Shulan, Jia, Rongfei, Li, Dongju, Shen, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628972/ https://www.ncbi.nlm.nih.gov/pubmed/26558272 http://dx.doi.org/10.1155/2015/453986 |
Ejemplares similares
-
The Long Non-Coding RNA SAMMSON Is a Regulator of Chemosensitivity and Metabolic Orientation in MCF-7 Doxorubicin-Resistant Breast Cancer Cells
por: Orre, Charlotte, et al.
Publicado: (2021) -
RBMS2 Chemosensitizes Breast Cancer Cells to Doxorubicin by Regulating BMF Expression
por: Xu, Feng, et al.
Publicado: (2022) -
Mir-153-3p Modulates the Breast Cancer Cells’ Chemosensitivity to Doxorubicin by Targeting KIF20A
por: Rahman, Khalil Ur, et al.
Publicado: (2023) -
Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
por: Riganti, Chiara, et al.
Publicado: (2013) -
Retraction: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
Publicado: (2020)